Article

Anjee Davis on the Future of Research and Advocacy in Colorectal Cancer

Author(s):

Anjee Davis

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates. We spoke with Davis at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago in May and June.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
Image of a woman wearing a headband and glasses
An Expert Breaks Down Lymphedema Following Cancer Care
Image of man.
Early Detection and Screening is Key for Esophageal Cancer
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Image of doctor.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
CURE spoke with Andy Guinigundo to discuss the role that biomarkers play for patients with breast cancer.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Image of doctor.
Machine Learning Improves Transplant Risk Assessment in Myelofibrosis
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
Breaking Down Kidney Cancer Treatment Advancements and Providing Hope
Related Content
Image of Clinical trial text.
April 12th 2025

First Patient Dosed With KSQ-004EX In Solid Tumor Clinical Trial

Alex Biese
KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Graphic with the words "FDA APPROVED" resembling a stamp of approval
April 8th 2025

FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer

Alex Biese
The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.
Diagnosed with stage 3b colorectal cancer, Joe Bullock underwent surgery and chemotherapy, achieving NED status.
April 7th 2025

How ‘Man in the Mirror’ Reflects a Cancer Journey

Joe Bullock
I always wanted to make a difference, but I never expected my biggest impact to come through cancer.